Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mania associated with interferon alpha2b treatment.

K K Basanth1, R Jacob, K S Jacob

  • 1Department of Psychiatry, Christian Medical College, Vellore-632002, Tamil Nadu, India. basanth@cmcvellore.ac.in

Journal of Postgraduate Medicine
|July 21, 2006
PubMed
Summary

Interferon alfa-2b can cause neuropsychiatric side effects like mania, particularly in hepatitis B patients. Dose adjustments during interferon therapy may trigger mania, highlighting the need for careful monitoring and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Social Skills Training Groups in Persons with Severe Mental Illness: A Pre-Post Intervention Study.

Indian journal of psychological medicine·2022
Same author

Intrinsic capacity and its associations with incident dependence and mortality in 10/66 Dementia Research Group studies in Latin America, India, and China: A population-based cohort study.

PLoS medicine·2021
Same author

Development and validation of Vellore Inventory of Life Skills among people with severe mental illness.

Indian journal of psychiatry·2021
Same author

Mental Health Legislation: The validity of divergent views.

The National medical journal of India·2021
Same author

Reforming medical education in India: Evolution before revolution.

The National medical journal of India·2021
Same author

A Qualitative Study Exploring the Lived Experience of Unemployment Among People with Severe Mental Illness.

Indian journal of psychological medicine·2021

Area of Science:

  • Neuropsychiatry
  • Hepatology
  • Pharmacology

Background:

  • Neuropsychiatric side effects, including psychosis and depression, are recognized adverse events associated with Interferon alfa-2b therapy.
  • While mania is a reported side effect, its specific association with interferon treatment for hepatitis B is less common.
  • The increasing use of interferon in developing countries necessitates a thorough understanding of its potential side effects.

Observation:

  • A case of mania with psychotic symptoms is presented in a 21-year-old female undergoing interferon treatment for hepatitis B infection.
  • This case suggests a potential link between dose reductions or treatment pauses and the onset of manic episodes.
  • A family history of mood disorders may represent a risk factor for developing interferon-induced mania.

Findings:

Related Experiment Videos

  • Interferon-induced mania can present with atypical symptoms.
  • The condition appears to respond favorably to standard antimanic drug treatments.
  • Dose modifications during interferon therapy are implicated as potential triggers for manic episodes.

Implications:

  • Healthcare providers should maintain a high index of suspicion for neuropsychiatric side effects, including mania, in patients receiving interferon.
  • Awareness of atypical presentations and potential risk factors like family history is crucial for early diagnosis.
  • Prompt management with antimanic medications is effective, and understanding these aspects is vital given the expanding use of interferon.